RxDoctor Payments Data

Michael Wang, MD

Neurological Surgery · Miami, FLNPI 1053347906

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.5%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 31.4% of the total. Among neurological surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,198,069in general payments, 2019–2025

Across 1,142 payments — averaging $1924.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$690K
  • Medical Device Business Services, Inc.$373K
  • Medtronic$332K
  • Stryker$261K
  • Spineology Inc.$172K
  • Globus Medical$128K
  • plus $242K from 34 others
$401,036in research payments, 2019–2025

Across 27 payments — averaging $14,853 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineology Inc.$256K
  • Pfizer$145K
  • Medtronic$450

What the payments were for

  • Royalty or licence$818,28337%
  • Consulting fees$1,132,53752%
  • Speaking & faculty fees$89,2384%
  • Travel & lodging$104,9905%
  • Food & beverage$42,0082%
  • Education$100%
  • Gifts$40%
  • Entertainment$5990%
  • Ownership interest$10,4000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,198,069 in reported general payments places this provider in the 95th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida

Medicare billing

Part B allowed, 2024
$1,152,577
Medicare patients
661
Services billed
2,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin474$6,014
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen155$4,853
Naloxone Hcl47$2,802
Tizanidine Hcl168$2,560
Pregabalin107$2,296
Celecoxib87$2,037
Cyclobenzaprine Hcl137$1,746
Methylprednisolone192$1,382
Meloxicam448$1,223
Diclofenac Sodium70$1,214
Baclofen58$1,099
Tramadol Hcl164$878
Hydromorphone Hcl18$394
Methocarbamol27$342
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$300

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →